Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Case ReportClinical Studies

Primary Neuroendocrine Carcinoma of the Appendix: A Case Report and Review of the Literature

KODAI TOMIOKA, YOSHIHIRO FUKOE, YUGEN LEE, MASAHIRO LEE, YUSUKE WADA, TAKESHI AOKI and MASAHIKO MURAKAMI
Anticancer Research June 2013, 33 (6) 2635-2638;
KODAI TOMIOKA
1Department of Gastroenterological Surgery, Shiroyama Hospital, Ota, Gunma, Japan
2Department of Gastroenterological and General Surgery, Showa University Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHIHIRO FUKOE
1Department of Gastroenterological Surgery, Shiroyama Hospital, Ota, Gunma, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: inquiry{at}shiroyama-hospital.or.jp
YUGEN LEE
1Department of Gastroenterological Surgery, Shiroyama Hospital, Ota, Gunma, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAHIRO LEE
1Department of Gastroenterological Surgery, Shiroyama Hospital, Ota, Gunma, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUSUKE WADA
2Department of Gastroenterological and General Surgery, Showa University Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKESHI AOKI
2Department of Gastroenterological and General Surgery, Showa University Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAHIKO MURAKAMI
2Department of Gastroenterological and General Surgery, Showa University Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Aim: We report on a rare case of appendiceal primary neuroendocrine carcinoma (NEC) and discuss three cases previously described. Case Report: A 58-year-old woman presented with acute abdominal pain and a low-grade fever. She was diagnosed with acute appendicitis and underwent laparoscopic appendectomy. Pathological examination of the resected specimen revealed NEC. Immunohistochemical analyses were positive for synaptophysin, chromogranin, and CD-56. The tumour was high grade and the Ki-67 index was >20%. Primary NEC of the appendix is extremely rare. To our knowledge, this is the first case report of an appendiceal NEC that meets the 2010 diagnostic criteria of the World Health Organization. Conclusion: Due to its non-specific clinical presentation, NEC is often misdiagnosed as appendicitis; however, it can advance rapidly and carries a very poor prognosis, despite chemotherapy. In the future, a treatment protocol for immunohistochemical analyses should be established to improve the survival rate.

  • Neuroendocrine
  • carcinoma
  • appendix
  • NET
  • NEC

Neuroendocrine cells exist throughout the human body (1). Neuroendocrine tumours (NETs) are a heterogeneous group of neoplasms composed of cells containing dense-core neuroendocrine secretory granules in the cytoplasm (2). The World Health Organization (WHO) grouped high-grade NETs with neuroendocrine carcinoma (NEC) in the 2010 classification of the NETs (3). The gastrointestinal tract has the largest proportion of neuroendocrine cells (1), i.e. approximately two-thirds of NETs; one-quarter of these cells are present in the lungs and the remainder, in other endocrine tissues (4, 5). However, NETs account for only 2% of all gastrointestinal tract malignancies (2). The small intestine is most commonly affected, followed by the rectum and then the appendix (6). Here, we describe a very rare case of NEC in the appendix without any metastases and present a review of the literature. To our knowledge, this is the first case reported which meets the 2010 WHO diagnostic criteria.

Case Report

A 58-year-old woman was referred to our hospital with acute severe pain in the right lower quadrant of the abdomen and a low-grade fever. Computed-tomography (CT) of the abdomen showed an enlarged appendix and thickening of the appendiceal wall, with fluid accumulation, suggestive of an abscess (Figure 1). She was clinically diagnosed with acute appendicitis and underwent laparoscopic appendectomy. During the operation, the ileocecal region was noted to be severely inflamed and thickly covered with omentum. The appendix was noticeably enlarged (Figure 2). The patient had an uneventful postoperative course and was discharged from the hospital on postoperative day 7. Pathological examination of the resected specimen showed a poorly-differentiated adenocarcinoma intermingled with signet ring-like cancer cells mainly located in the muscle layer. A few tumour cells were present in the mucosa. On the basis of these results, metastasis from an occult cancer was strongly suspected. Laboratory tests, including those for carcinoembryonic antigen (CEA) and CA19-9, were normal. Whole-body 18F-fluorodeoxyglucose positron-emission tomography was performed to identify a primary focus, but no abnormal accumulations were detected. Colonoscopy did not yield any findings either. As some cancer cells were observed in the resection facer, ileocecal resection with lymphadenectomy was performed after a few weeks. The patient was discharged on postoperative day 13 without any complications. Immunohistochemical analysis of the specimen revealed neuroendocrine neoplasia with positive expression of synaptophysin, chromogranin, and CD-56. It was a high-grade neoplasia, in terms of mitotic count, with a low degree of differentiation, and the Ki-67 index was 51.8%. According to the WHO classification and European Neuroendocrine Tumor Society (ENETS) (7), the final diagnosis was a primary NEC of the appendix (stage IIa; T2, ly0, v0, N0, M0 according to TNM classification by ENETS). Although some studies recommend adjuvant or intraperitoneal chemotherapy to prolong survival (8-10), the patient declined chemotherapy. The patient is currently well and has had no tumour recurrence for five months since the first surgery.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Computed tomography showed an enlarged appendix with a thickened wall (white asterisk).

Discussion

Neuroendocrine cells are distributed throughout the body and can be found in the gastrointestinal tract, pancreas, lung, thyroid, adrenal gland, etc. The gastrointestinal tract has the highest proportion of neuroendocrine cells. NETs in the gastrointestinal tract occur predominantly in the small intestine (44.7%), followed by the rectum (19.6%), appendix (16.7%), colon (10.6%), and stomach (7.2%) (6). According to a Swedish study, the incidence of all gastrointestinal NETs is approximately 2.0 per 100,000 in men and 2.4 per 100,000 in women (11). Moreover, the annual incidence of NETs of the appendix is 0.15-0.6 per 100,000 persons according to the Surveillance Epidemiology and End Results (SEER) database. The incidence of appendectomies performed for any indication is approximately 3-9 per 1,000 persons, and thus, this is a relatively common surgery (7). However, NEC of the colon and rectum are very rare (1). In particular, NEC accounts for 0.1-3.9% of all colorectal malignancies (1, 10). Moreover, it is extremely rare in the appendix. A literature review in PubMed revealed only three similar case reports, including mixed adenoneuroendocrine carcinoma (MANEC). A few case reports have described NETs of the appendix, but they were almost all cases of carcinoid tumours without any Ki-67 examination. Therefore, to our knowledge, our case is the first to present NEC of the appendix meeting the 2010 WHO diagnostic criteria for NETs and NEC (Table I) (3, 12-14).

It can be difficult to diagnose NEC preoperatively. On haematoxylin-eosin staining, NEC can be quite similar to poorly-differentiated adenocarcinoma (15) and hence requires further immunohistochemical analyses, such as those for synaptophysin, chromogranin, and CD-56. Although an early diagnosis is important to ensure appropriate management, it can be exceedingly difficult since the clinical presentation mimics acute appendicitis with right lower-quadrant abdominal pain and the lack of specific symptoms. In fact, most cases have been diagnosed as acute appendicitis, including that of our patient, and following pathological examination, patients have required additional operations such as ileocecal resection or right hemicolectomy.

NET is a low-grade malignancy and in general, no additional therapy is required (16). Although the prognosis of appendiceal NETs is generally excellent, NEC or MANEC have very poor outcomes and can progress very rapidly (7). The lymph node metastasis rate is 58%, while the hepatic metastasis rate is 39–66%; the one-year survival rate was 37-46% (1,17,18). Its biological characterization is similar to that of pulmonary small cell carcinoma, and some reports recommend adjuvant chemotherapy with cicplatin+irinotecan (19, 20). Other studies suggest cytoreductive surgery with adjuvant or intraperineal chemotherapy (8-10). In our case, the patient declined chemotherapy following the second operation. Due to its high-grade nature, NEC has an extremely poor prognosis regardless of therapy, and the most important prognostic predictors are disease stage, tumour size, and nodal status (7). Therefore, malignancy should always be excluded in any appendectomy, and careful follow-up should be arranged in case any additional operations or therapies are required.

In conclusion, NEC of the appendix is an extremely rare and aggressive disease. In many cases, it may be erroneously diagnosed as acute appendicitis. When encountering acute appendicitis, malignancy and NETs should be considered in the differential diagnosis. If any unusual findings are noted perioperatively, pathological examination should be conducted thoroughly and potentially include immunohistochemical analyses, such as those for synaptophysin, chromogranin, and CD-56. As more cases of NEC are diagnosed, we hope that a treatment protocol will be established to improve the survival rate of such patients.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Laparoscopic appendectomy. a: The ileocecal region is severely inflamed and covered with omentum. b: After dissecting the mesoappendix, the appendix was found to be enlarged. c: Handling of the roots of the appendix. d: Removal of the resected appendix.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

a: Macroscopic imaging of the appendix. b: Poorly-differentiated neuroendocrine carcinoma (hematoxylin-eosin) (×40). c: Positive synaptophysin expression (×20). d: Positive chromogranin expression (×20). e: Positive CD-56 expression (×20). f: A high cell-proliferation index (Ki-67) (×20).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Literature review of primary NEC and MANEC of the appendix.

Acknowledgements

We thank the patient for allowing us to publish this case.

Footnotes

  • This article is freely accessible online.

  • Received April 6, 2013.
  • Revision received April 26, 2013.
  • Accepted April 30, 2013.
  • Copyright© 2013 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Bernick PE,
    2. Klimstra DS,
    3. Shia J,
    4. Minsky B,
    5. Saltz L,
    6. Shi W,
    7. Thaler H,
    8. Guillem J,
    9. Paty P,
    10. Cohen AM,
    11. Wong WD
    : Neuroendocrine carcinoma of the colon and rectum. Dis Colon Rectum 47: 163-169, 2006.
    OpenUrl
  2. ↵
    1. Estrozi B,
    2. Bacchi CE
    : Neuroendocrine tumors involving the gastroenteropancreatic tract: A clinicopathological evaluation of 773 cases. Clinics 66: 1671-1675, 2011.
    OpenUrlPubMed
  3. ↵
    1. Bosman FT,
    2. Carneiro F,
    3. Hruban RH,
    4. Theise ND
    : WHO Classification of Tumors of the Digestive System 4th ed. Lyon, IARC Press, pp. 417, 2010.
  4. ↵
    1. Modlin IM,
    2. Lye KD,
    3. Kidd MA
    : 5-Decade analysis of 13,715 carcinoid tumors. Cancer 97: 934-959, 2003.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Yunes RN
    : Neuroendocrine tumors: A registry of 1,000 patients. Rev Assoc Med Bras 54: 305-307, 2008.
    OpenUrlPubMed
  6. ↵
    1. Maggard MA,
    2. O'Connell JB,
    3. Ko CY
    : Updated population-based review of carcinoid tumors. Ann Surg 240: 117-122, 2004.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Pape UF,
    2. Perren A,
    3. Niederle B,
    4. Gross D,
    5. Gress T,
    6. Costa F,
    7. Arnold R,
    8. Denecke T,
    9. Plöckinger U,
    10. Salazar R,
    11. Grossman A,
    12. all other Barcelona Consensus Conference participants
    : ENETS Consensus Guideline for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Illeum and the Appendix Including Goblet Cell Carcinomas. Neuroendocrinology 95: 135-156, 2012.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Tang LH,
    2. Shia J,
    3. Soslow RA,
    4. Dhall D,
    5. Wong WD,
    6. O'Reilly E,
    7. Qin J,
    8. Paty P,
    9. Weiser MR,
    10. Guillem J,
    11. Temple L,
    12. Sobin LH,
    13. Klimstra DS
    : Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol 32: 1429-1443, 2008.
    OpenUrlCrossRefPubMed
    1. Mahteme H,
    2. Sugarbaker PH
    : Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin. Br J Surg 91: 1168-1173, 2004.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Thomas RM,
    2. Sobin LH
    : Gastrointestinal cancer. Cancer 75: 154-170, 1995.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Hemminki K,
    2. Li X
    : Incidence trends and risk factors of carcinoid tumors: A nationwide epidemiologic study from Sweden. Cancer 92: 2204-2210, 2001.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Thomas RE,
    2. Maude K,
    3. Rotimi O
    : A case of intussuscepted neuroendocrine carcinoma of the appendix. World J Gastroenterol 12: 971-973, 2006.
    OpenUrlPubMed
    1. Couvelard A
    : Appendicular pathology. Mixed endocrine carcinoma with poorly differentiated large cell component. Ann Pathol 30: 124-129, 2010.
    OpenUrlPubMed
  12. ↵
    1. Tanaka S,
    2. Shimode Y,
    3. Akami T,
    4. Mugitani T,
    5. Takemura M,
    6. Shimizu K,
    7. Ogino S,
    8. Nakao T,
    9. Ishida E
    : A case of appendiceal mixed adenoneuroendocrine carcinoma after appendectomy. Jpn J gastroenterol Surg 45: 1121-1128, 2012.
    OpenUrl
  13. ↵
    1. Simon SR,
    2. Fox K
    : Neuroendocrine carcinoma of the colon. J Clin Gastroenterol 17: 304-307, 1993.
    OpenUrlPubMed
  14. ↵
    1. Kloppel G,
    2. Couvelard A,
    3. Perren A,
    4. Komminoth P,
    5. McNicol AM,
    6. Nilsson O,
    7. Scarpa A,
    8. Scoazec JY,
    9. Wiedenmann B,
    10. Papotti M,
    11. Rindi G,
    12. Plockinger U
    : ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 90: 162-166, 2009.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Hirose K,
    2. Shinohara T,
    3. Saji Y
    : A case of neuroendocrine cell carcinoma of the rectum. J Jpn Surg Assoc 65: 282-288, 2004 (in Japanese).
    OpenUrl
  16. ↵
    1. Tsujie M,
    2. Shibata N,
    3. Nomura T,
    4. Okuda H,
    5. Takeda T
    : A case of endocrine cell carcinoma of the rectum. Jpn J Gastroenterol Surg 36: 240-244, 2003 (in Japanese).
    OpenUrl
  17. ↵
    1. Kulke MH,
    2. Wu B,
    3. Ryan DP,
    4. Enzinger PC,
    5. Zhu AX,
    6. Clark JW,
    7. Earle CC,
    8. Michelini A,
    9. Fuchs CS
    : A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors. Dig Dis Sci 51: 1033-1038, 2006.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Okita NT,
    2. Kato K,
    3. Takahashi D,
    4. Hirashima Y,
    5. Nakajima TE,
    6. Matsubara J,
    7. Hamaguchi T,
    8. Yamada Y,
    9. Shimada Y,
    10. Taniguchi H,
    11. Shirao K
    : Neuroendocrine tumors of the stomach: Chemo-therapys with cisplatin plus irinotecan is effective for gastric poorly differentiated neuroendocrine carcinoma. Gastric Cancer 14: 161-165, 2011.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 33, Issue 6
June 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Primary Neuroendocrine Carcinoma of the Appendix: A Case Report and Review of the Literature
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Primary Neuroendocrine Carcinoma of the Appendix: A Case Report and Review of the Literature
KODAI TOMIOKA, YOSHIHIRO FUKOE, YUGEN LEE, MASAHIRO LEE, YUSUKE WADA, TAKESHI AOKI, MASAHIKO MURAKAMI
Anticancer Research Jun 2013, 33 (6) 2635-2638;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Primary Neuroendocrine Carcinoma of the Appendix: A Case Report and Review of the Literature
KODAI TOMIOKA, YOSHIHIRO FUKOE, YUGEN LEE, MASAHIRO LEE, YUSUKE WADA, TAKESHI AOKI, MASAHIKO MURAKAMI
Anticancer Research Jun 2013, 33 (6) 2635-2638;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Case Report
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Appendiceal Neuroendocrine Tumor: Clinicopathologic Characteristics of Six Cases and Review of the Literature
  • Google Scholar

More in this TOC Section

  • Comparison of RATS Lobectomy and VATS Lobectomy for Early-stage Non-small Cell Lung Cancer
  • Effectiveness of Chemotherapy With/Without Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Population-based Target Trial Emulation Study
  • Genomic Profiling of Cancerous Areas, Dysplasia, and Background Mucosa in Ulcerative Colitis-associated Colorectal Cancer
Show more Clinical Studies

Keywords

  • neuroendocrine
  • carcinoma
  • appendix
  • NET
  • NEC
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire